TY - JOUR
T1 - National veterans health administration hospitalizations for syncope compared to acute myocardial infarction, fracture, or pneumonia in community-dwelling elders
T2 - Outpatient medication and comorbidity profiles
AU - French, Dustin D.
AU - Campbell, Robert
AU - Spehar, Andrea
AU - Rubenstein, Laurence Z.
AU - Accomando, John
AU - Cunningham, Francesca
PY - 2006/6
Y1 - 2006/6
N2 - The authors used 2 national Veterans Health Administration databases to identify outpatient medications and all 30 Elixhauser comorbidities for 2579 unique patients, age 65+years, hospitalized for syncope in fiscal year 2004. For comparison, we identified other elderly patients hospitalized with acute myocardial infarction (N = 4491), fracture (N = 2797), or pneumonia (N = 9473). The categories of medications included drugs that affect the cardiovascular, central nervous, or the muscular skeletal system. The most notable differences between syncope compared to acute myocardial infarction patients occurred in central nervous system drugs in anticonvulsants/barbiturates, antidepressants, antihistamine/antinauseants, antipsychotics, and cholinesterase inhibitors (P < .0018). Comparing syncope patients with fracture patients, the central nervous medication profile was similar, but the cardiovascular medication profile differed (P < .0018); their hypertension comorbidities also differed (60.45% vs 46.34%); (P < .0016). These findings indicate significant potential associations that warrant further study. Studies linking national outpatient medications to hospitalizations for specific conditions can foster the development of more proactive pharmacovigilance systems.
AB - The authors used 2 national Veterans Health Administration databases to identify outpatient medications and all 30 Elixhauser comorbidities for 2579 unique patients, age 65+years, hospitalized for syncope in fiscal year 2004. For comparison, we identified other elderly patients hospitalized with acute myocardial infarction (N = 4491), fracture (N = 2797), or pneumonia (N = 9473). The categories of medications included drugs that affect the cardiovascular, central nervous, or the muscular skeletal system. The most notable differences between syncope compared to acute myocardial infarction patients occurred in central nervous system drugs in anticonvulsants/barbiturates, antidepressants, antihistamine/antinauseants, antipsychotics, and cholinesterase inhibitors (P < .0018). Comparing syncope patients with fracture patients, the central nervous medication profile was similar, but the cardiovascular medication profile differed (P < .0018); their hypertension comorbidities also differed (60.45% vs 46.34%); (P < .0016). These findings indicate significant potential associations that warrant further study. Studies linking national outpatient medications to hospitalizations for specific conditions can foster the development of more proactive pharmacovigilance systems.
KW - Comorbidity
KW - Drugs
KW - Hospitalization
KW - Pharmacovigilance
KW - Syncope
KW - Veterans
UR - http://www.scopus.com/inward/record.url?scp=33745241807&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745241807&partnerID=8YFLogxK
U2 - 10.1177/0091270006288452
DO - 10.1177/0091270006288452
M3 - Article
C2 - 16707407
AN - SCOPUS:33745241807
SN - 0091-2700
VL - 46
SP - 613
EP - 619
JO - Journal of Clinical Pharmacology
JF - Journal of Clinical Pharmacology
IS - 6
ER -